A U3 snoRNA gene isolated from a Chlamydomonas reinhardtii (CRE:) genomic library contains putative pol III-specific transcription signals similar to those of RNA polymerase III-specific small nuclear (sn)RNA genes of higher plants. The 222 nt long CRE: U3 snoRNA was immunoprecipitated by anti-gamma-mpppN antisera, but not by anti-m(2,2,7)G antibodies, supporting the notion that it is a RNA polymerase III transcript. Tagged CRE: U3 snoRNA gene constructs were expressed in CRE: cells. Results of chemical and enzymatic structure probing of CRE: U3 snoRNA in solution and of DMS modification of CRE: U3 snoRNA under in vivo conditions revealed that the two-hairpin structure of the 5'-domain that is found in solution is no longer detected under in vivo conditions. The observed differences can be explained by the formation of several base pair interactions with the 18S and 5'-ETS parts of the pre-rRNA. A model that involves five intermolecular helices is proposed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC102673 | PMC |
| http://dx.doi.org/10.1093/nar/28.15.2959 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras;Tp53 (KPC) mice, a genetically engineered model of pancreatic cancer.
Cancer Chemother Pharmacol
December 2018
Rare Tumor Initiative (RTI), Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Hatfield Center, 10 Center Drive, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
Article Synopsis
- Metarrestin is a new small molecule that targets the perinucleolar compartment, specifically designed for treating metastatic cancer cells, and this study assesses its pharmacokinetic properties and how it affects cancer-related biological markers.
- The study involved administering different doses of metarrestin to mice with pancreatic tumors, revealing it has a good oral bioavailability and demonstrates significant tissue concentration in tumors, suggesting effective drug delivery.
- Results indicated that metarrestin achieves high levels in tumor tissues, with a strong correlation between dosage and drug concentration, alongside a favorable influence on certain mRNA expressions related to tumor biology.
Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome.
J Clin Invest
March 2018
Medical Research Council (MRC) Metabolic Diseases Unit, University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
Profound hyperphagia is a major disabling feature of Prader-Willi syndrome (PWS). Characterization of the mechanisms that underlie PWS-associated hyperphagia has been slowed by the paucity of animal models with increased food intake or obesity. Mice with a microdeletion encompassing the Snord116 cluster of noncoding RNAs encoded within the Prader-Willi minimal deletion critical region have previously been reported to show growth retardation and hyperphagia.
View Article and Find Full Text PDFAdult-onset deletion of the Prader-Willi syndrome susceptibility gene in mice results in reduced feeding and increased fat mass.
Transl Pediatr
April 2017
Neuroscience Research Department, Garvan Institute of Medical Research, NSW, Australia.
Background: The imprinted small nucleolar RNA (snoRNA) Snord116 is implicated in the aetiology of Prader-Willi syndrome (PWS), a disease associated with hyperphagia and obesity. Germline deletion of in mice has been found to lead to increased food intake but not to the development of obesity. To determine the role of Snord116 independent of potential compensatory developmental factors, we investigated the effects of conditional adult-onset deletion of in mice.
View Article and Find Full Text PDFAmbient temperature modulates the effects of the Prader-Willi syndrome candidate gene Snord116 on energy homeostasis.
Neuropeptides
February 2017
Neuroscience Division, Garvan Institute of Medical Research, Sydney, Australia.
Germline deletion of the Prader-Willi syndrome (PWS) candidate gene Snord116 in mice leads to some classical symptoms of human PWS, notably reductions in body weight, linear growth and bone mass. However, Snord116 deficient mice (Snord116) do not develop an obese phenotype despite their increased food intake and the underlying mechanism for that is unknown. We tested the phenotypes of germline Snord116 as well as neuropeptide Y (NPY) neuron specific Snord116/NPY mice at 30°C, the thermoneutral temperature of mice, and compared these to previous reports studies conducted at normal room temperature.
View Article and Find Full Text PDFA humanoid mouse model of autism.
Brain Dev
October 2010
Laboratory of Integrative Bioscience, Graduate School of Biomedical Sciences, Hiroshima University, Minami, Hiroshima 734-8553, Japan.
Even now fruit of the human genome project is available, we have difficulties to approach neuropsychiatric disorders at the molecular level. Autism is a complex psychiatric illness but has received considerable attention as a developmental brain disorder not only from basic researchers but also from society. Substantial evidence suggests that chromosomal abnormalities contribute to autism risk.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!